Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder.
Clin Cancer Res
; 23(2): 503-513, 2017 Jan 15.
Article
in En
| MEDLINE
| ID: mdl-27435393
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Carcinoma
/
STAT3 Transcription Factor
/
CCAAT-Enhancer-Binding Protein-delta
/
ErbB Receptors
Limits:
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Country of publication:
United States